Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Star
6890.5000
-16.00
(
-0.23
%)
NSE
Jul 07, 2025
10:38 AM
New 52W High in past week
Volume:
27,702
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
05 Nov 2019
6890.50
-0.23%
Divi's Labs (ADD): Good Q2 beat; FY20 margin guidance cut is negative
Buy:
Divi's Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 1765
Recommendation
Target
BOB Capital Markets Ltd.
Overall Revenue/EBITDA were 13% ahead of our estimates but largely in-line with consensus.
Divi's Laboratories .. has an
average target
of 5900.88 from 8 brokers.
More from Divi's Laboratories Ltd.
Recommended
Market trades flat, Tourism Finance Corp's board to meet on July 10 to consider a stock split
Trendlyne Marketwatch |
07 Jul 2025, 10:21AM
Five Interesting Stocks Today - July 04, 2025
The Baseline |
04 Jul 2025
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022